{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zavegepant", "query": { "intervention": "Zavegepant" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Zavegepant&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T20:46:36.558Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04804033", "title": "A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "BHV-3500 (zavegepant)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1753, "start_date": "2021-03-26", "completion_date": "2024-03-21", "has_results": true, "last_update_posted_date": "2025-03-27", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 116, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Canoga Park, California + 88 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Colton", "state": "California" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04804033" }, { "nct_id": "NCT03872453", "title": "Acute Treatment Trial in Adult Subjects With Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Zavegepant", "type": "DRUG" }, { "name": "Zavegepant matching placebo", "type": "DRUG" }, { "name": "Intranasal Aptar Pharma Unit Dose System", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2154, "start_date": "2019-03-25", "completion_date": "2019-11-11", "has_results": true, "last_update_posted_date": "2023-09-25", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 82, "location_summary": "Mobile, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 75 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Encino", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03872453" }, { "nct_id": "NCT06137703", "title": "A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Biological Availability" ], "interventions": [ { "name": "Zavegepant 100mg non-enteric coated soft gel capsule", "type": "DRUG" }, { "name": "Zavegepant 100mg immediate release tablet", "type": "DRUG" }, { "name": "Zavegepant 2 x 100mg immediate release tablets", "type": "DRUG" }, { "name": "Zavegepant 4 x 25mg enteric coated soft gel capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 52, "start_date": "2022-08-24", "completion_date": "2022-12-07", "has_results": true, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06137703" }, { "nct_id": "NCT04571060", "title": "Randomized Trial in Adult Participants With Acute Migraines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Zavegepant", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1978, "start_date": "2020-10-27", "completion_date": "2021-10-22", "has_results": true, "last_update_posted_date": "2023-04-24", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 94, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Chandler, Arizona + 86 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04571060" }, { "nct_id": "NCT07714369", "title": "Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cluster Headache" ], "interventions": [ { "name": "Zavegepant 20 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 40, "start_date": "2026-10-01", "completion_date": "2028-05-01", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07714369" }, { "nct_id": "NCT06995729", "title": "A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Treatment of Migraine" ], "interventions": [ { "name": "Zavegepant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 16, "start_date": "2025-05-16", "completion_date": "2027-08-12", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 13, "location_summary": "Little Rock, Arkansas • Washington D.C., District of Columbia • Hinesville, Georgia + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Hinesville", "state": "Georgia" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT06995729" }, { "nct_id": "NCT06985342", "title": "Acute Migraine Treatment in the ED With Gepants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine Headaches" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" }, { "name": "Zavegepant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2025-06-05", "completion_date": "2026-02-04", "has_results": false, "last_update_posted_date": "2026-04-29", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06985342" }, { "nct_id": "NCT06453356", "title": "A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Breast-Feeding Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Zavegepant 10mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "18 Years to 55 Years · Female only" }, "enrollment_count": 12, "start_date": "2024-06-10", "completion_date": "2024-09-26", "has_results": false, "last_update_posted_date": "2024-10-08", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 2, "location_summary": "Springfield, Missouri", "locations": [ { "city": "Springfield", "state": "Missouri" }, { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06453356" }, { "nct_id": "NCT04346615", "title": "Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "COVID-19 Infection" ], "interventions": [ { "name": "Zavegepant (BHV-3500)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2020-04-25", "completion_date": "2022-04-29", "has_results": true, "last_update_posted_date": "2024-05-02", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 6, "location_summary": "Washington D.C., District of Columbia • Philadelphia, Pennsylvania • Charleston, South Carolina", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04346615" }, { "nct_id": "NCT04408794", "title": "Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Acute Migraine" ], "interventions": [ { "name": "Zavegepant (BHV-3500)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 974, "start_date": "2020-06-29", "completion_date": "2021-12-23", "has_results": true, "last_update_posted_date": "2023-05-18", "last_synced_at": "2026-09-07T20:46:36.558Z", "location_count": 67, "location_summary": "Huntsville, Alabama • Mobile, Alabama • Tucson, Arizona + 62 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04408794" } ] }